Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

gadomelitol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Objective To evaluate the utility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) using macromolecular contrast… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2014
2014
Dynamic MR biomarkers (T2*-weighted or susceptibility-based and T1-weighted or relaxivity-enhanced) have been applied to assess… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2013
2013
Abstract Background. Cancer patients showing highly elevated interstitial fluid pressure (IFP) in the primary tumor may benefit… Expand
2012
2012
BackgroundHigh interstitial fluid pressure (IFP) in the primary tumor is associated with poor disease-free survival in locally… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
BACKGROUND AND PURPOSE Extensive hypoxia and high interstitial fluid pressure (IFP) in the primary tumor may cause resistance to… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2009
2009
Objectives:The aim of this study was to evaluate lesion enhancement (LE) and contrast-to-noise ratio (CNR) properties of P846, a… Expand
2009
2009
Objective To compare P792 (gadomelitol, a rapid clearance blood pool MR contrast agent) with gadolinium… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2008
2008
The effect of two novel therapeutic agents on tumour haemodynamics was investigated using a fast dynamic contrast‐enhanced (DCE… Expand
2008
2008
To assess which MRI‐derived kinetic parameters reflect decreased transvascular and interstitial transport when low‐ and high… Expand
2005
2005
The study evaluates the tumor distribution of the rapid clearance blood pool agent (RCBPA) gadomelitol, in a breast tumor model… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3